Capricor Therapeutics Inc
F:4LN2
Capricor Therapeutics Inc
F:4LN2
Price:
20.76
EUR
1.02%
Market Closed
Market Cap:
€663.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Capricor Therapeutics Inc
F:4LN2
|
US |
|
Pernod Ricard SA
PAR:RI
|
FR |
|
Natwest Group PLC
F:RYSD
|
UK |
|
Iridium Communications Inc
NASDAQ:IRDM
|
US |
|
Microvast Holdings Inc
F:2OZA
|
US |
|
Intesa Sanpaolo SpA
MIL:ISP
|
IT |
|
I
|
Intesa Sanpaolo SpA
BMV:ISPN
|
IT |
|
C
|
Clean Harbors Inc
F:CH6
|
US |
Wall St Price Targets
4LN2 Price Targets Summary
Capricor Therapeutics Inc
Capricor Therapeutics Inc
Wall Street analysts forecast 4LN2 stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 4LN2 is 12.04 EUR with a low forecast of 8.45 EUR and a high forecast of 14.56 EUR.
Lowest Forecast
Price Target
8.45
EUR
59% Downside
Average Forecast
Price Target
12.04
EUR
42% Downside
Highest Forecast
Price Target
14.56
EUR
30% Downside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4LN2's stock price target?
Price Target
12.04
EUR
12.04
EUR
According to Wall Street analysts, the average 1-year price target for 4LN2 is 12.04 EUR with a low forecast of 8.45 EUR and a high forecast of 14.56 EUR.
